FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Overview Fund Activity
Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

57 hedge funds and large institutions have $73.5M invested in F-star Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
12
Closed
3
Calls
$2.08M
Puts
–
Net Calls
+$2.08M
Net Calls Change
-$332K

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$10.4M
2
BlackRock
2
BlackRock
New York
$7.02M
3
SFM
3
Sphera Funds Management
Israel
$530K
4
HP
4
Hikari Power
Japan
$556K
5
FI
5
Fosun International
China
$274K

Top Sellers

1
SI
1
Sofinnova Investments
California
$0
2
Jennison Associates
2
Jennison Associates
New York
$5.5M
3
SCM
3
Stonepine Capital Management
Oregon
$0
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$2.62M
5
CWG
5
C WorldWide Group
Denmark
$541K
Name Holding Trade Value Shares
Change 		Shares
Change %
Twin Tree Management
51
Twin Tree Management
Texas
$4K +$4K +94 New
AWM
52
Arbor Wealth Management
Florida
$3K +$3K +75 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$2.05K -$1.76K -42 -46%
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$2K +$980 +24 +96%
Barclays
55
Barclays
United Kingdom
$1K -$51.6K -1,289 -98%
GT
56
Glenmede Trust
Pennsylvania
$43 +$43 +1,042 New
SI
57
Sofinnova Investments
California
– -$2.29M -47,412 Closed
SCM
58
Stonepine Capital Management
Oregon
– -$856K -17,763 Closed
TRCT
59
Tower Research Capital (TRC)
New York
– -$7K -155 Closed
1 2
3